Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome

P. W. Lambert, P. B. De Oreo, I. Y. Fu, D. M. Kaetzel, K. von Ahn, B. W. Hollis, B. A. Roos

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Using newly developed and established extraction, Lipidex-5000 chromatography, normal phase gradient HPLC, and ligand binding assay techniques we have directly measured plasma and urine levels of vitamin D3 and its metabolites in seven normal subjects and seven patients with nephrotic syndrome and normal renal function. Significant reductions in the plasma levels of vitamin D,, 24,25(OH)2D3, 25,26(OH)2D,, and 1,25(OH)2D, were noted in all nephrotic patients. In conjunction with the plasma metabolite abnormalities, direct quantitative analysis of the urine in these patients revealed significant increases in nonconjugated 250HD,, 24,25(OH)2D3, and 1,25(OH)2D,. Significant correlations were noted between the plasma and/or urine metabolites and other mineral homeostatic parameters. The results indicate that the primary basis for the reductions in plasma vitamin D, and its metabolites in the nephrotic syndrome is enhanced urinary excretion. The findings of normal serum ionized Ca and i-PTH levels in the patients with nephrosis suggest that reductions in bound and not free forms of vitamin D3 metabolites in plasma may occur in the initial stages of the nephrotic syndrome.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalMetabolic Bone Disease and Related Research
Volume4
Issue number1
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Cholecalciferol
Nephrotic Syndrome
Urine
Vitamin D
Nephrosis
Minerals
Chromatography
High Pressure Liquid Chromatography
Ligands
Kidney
Serum

Keywords

  • Nephrotic Syndrome
  • Vitamin D Metabolites

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Surgery

Cite this

Lambert, P. W., De Oreo, P. B., Fu, I. Y., Kaetzel, D. M., von Ahn, K., Hollis, B. W., & Roos, B. A. (1982). Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome. Metabolic Bone Disease and Related Research, 4(1), 7-15. https://doi.org/10.1016/0221-8747(82)90003-0

Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome. / Lambert, P. W.; De Oreo, P. B.; Fu, I. Y.; Kaetzel, D. M.; von Ahn, K.; Hollis, B. W.; Roos, B. A.

In: Metabolic Bone Disease and Related Research, Vol. 4, No. 1, 01.01.1982, p. 7-15.

Research output: Contribution to journalArticle

Lambert, PW, De Oreo, PB, Fu, IY, Kaetzel, DM, von Ahn, K, Hollis, BW & Roos, BA 1982, 'Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome', Metabolic Bone Disease and Related Research, vol. 4, no. 1, pp. 7-15. https://doi.org/10.1016/0221-8747(82)90003-0
Lambert, P. W. ; De Oreo, P. B. ; Fu, I. Y. ; Kaetzel, D. M. ; von Ahn, K. ; Hollis, B. W. ; Roos, B. A. / Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome. In: Metabolic Bone Disease and Related Research. 1982 ; Vol. 4, No. 1. pp. 7-15.
@article{c67b6e16bbfc4a8b8f857bbcf9722099,
title = "Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome",
abstract = "Using newly developed and established extraction, Lipidex-5000 chromatography, normal phase gradient HPLC, and ligand binding assay techniques we have directly measured plasma and urine levels of vitamin D3 and its metabolites in seven normal subjects and seven patients with nephrotic syndrome and normal renal function. Significant reductions in the plasma levels of vitamin D,, 24,25(OH)2D3, 25,26(OH)2D,, and 1,25(OH)2D, were noted in all nephrotic patients. In conjunction with the plasma metabolite abnormalities, direct quantitative analysis of the urine in these patients revealed significant increases in nonconjugated 250HD,, 24,25(OH)2D3, and 1,25(OH)2D,. Significant correlations were noted between the plasma and/or urine metabolites and other mineral homeostatic parameters. The results indicate that the primary basis for the reductions in plasma vitamin D, and its metabolites in the nephrotic syndrome is enhanced urinary excretion. The findings of normal serum ionized Ca and i-PTH levels in the patients with nephrosis suggest that reductions in bound and not free forms of vitamin D3 metabolites in plasma may occur in the initial stages of the nephrotic syndrome.",
keywords = "Nephrotic Syndrome, Vitamin D Metabolites",
author = "Lambert, {P. W.} and {De Oreo}, {P. B.} and Fu, {I. Y.} and Kaetzel, {D. M.} and {von Ahn}, K. and Hollis, {B. W.} and Roos, {B. A.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/0221-8747(82)90003-0",
language = "English",
volume = "4",
pages = "7--15",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome

AU - Lambert, P. W.

AU - De Oreo, P. B.

AU - Fu, I. Y.

AU - Kaetzel, D. M.

AU - von Ahn, K.

AU - Hollis, B. W.

AU - Roos, B. A.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Using newly developed and established extraction, Lipidex-5000 chromatography, normal phase gradient HPLC, and ligand binding assay techniques we have directly measured plasma and urine levels of vitamin D3 and its metabolites in seven normal subjects and seven patients with nephrotic syndrome and normal renal function. Significant reductions in the plasma levels of vitamin D,, 24,25(OH)2D3, 25,26(OH)2D,, and 1,25(OH)2D, were noted in all nephrotic patients. In conjunction with the plasma metabolite abnormalities, direct quantitative analysis of the urine in these patients revealed significant increases in nonconjugated 250HD,, 24,25(OH)2D3, and 1,25(OH)2D,. Significant correlations were noted between the plasma and/or urine metabolites and other mineral homeostatic parameters. The results indicate that the primary basis for the reductions in plasma vitamin D, and its metabolites in the nephrotic syndrome is enhanced urinary excretion. The findings of normal serum ionized Ca and i-PTH levels in the patients with nephrosis suggest that reductions in bound and not free forms of vitamin D3 metabolites in plasma may occur in the initial stages of the nephrotic syndrome.

AB - Using newly developed and established extraction, Lipidex-5000 chromatography, normal phase gradient HPLC, and ligand binding assay techniques we have directly measured plasma and urine levels of vitamin D3 and its metabolites in seven normal subjects and seven patients with nephrotic syndrome and normal renal function. Significant reductions in the plasma levels of vitamin D,, 24,25(OH)2D3, 25,26(OH)2D,, and 1,25(OH)2D, were noted in all nephrotic patients. In conjunction with the plasma metabolite abnormalities, direct quantitative analysis of the urine in these patients revealed significant increases in nonconjugated 250HD,, 24,25(OH)2D3, and 1,25(OH)2D,. Significant correlations were noted between the plasma and/or urine metabolites and other mineral homeostatic parameters. The results indicate that the primary basis for the reductions in plasma vitamin D, and its metabolites in the nephrotic syndrome is enhanced urinary excretion. The findings of normal serum ionized Ca and i-PTH levels in the patients with nephrosis suggest that reductions in bound and not free forms of vitamin D3 metabolites in plasma may occur in the initial stages of the nephrotic syndrome.

KW - Nephrotic Syndrome

KW - Vitamin D Metabolites

UR - http://www.scopus.com/inward/record.url?scp=0020017922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020017922&partnerID=8YFLogxK

U2 - 10.1016/0221-8747(82)90003-0

DO - 10.1016/0221-8747(82)90003-0

M3 - Article

C2 - 6289039

AN - SCOPUS:0020017922

VL - 4

SP - 7

EP - 15

JO - Bone

JF - Bone

SN - 8756-3282

IS - 1

ER -